PUBLISHER: The Business Research Company | PRODUCT CODE: 1693251
PUBLISHER: The Business Research Company | PRODUCT CODE: 1693251
Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.
The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.
The medical device reimbursement market research report is one of a series of new reports from The Business Research Company that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $653.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.
The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $924.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.
The increasing demand for minimally invasive surgeries is expected to drive the growth of the medical device reimbursement market. Minimally invasive surgery (MIS) is a medical approach that uses specialized techniques and tools to perform surgeries with less disruption to the patient's body compared to traditional open surgery. Medical device reimbursement for minimally invasive surgeries offers benefits such as improved patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For example, in September 2023, the American Society of Plastic Surgeons (ASPS), a US-based organization, reported that 4,715,716 minimally invasive procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin) were performed in 2023, marking a 6% increase from the previous year. Additionally, dermal fillers were widely used, with 3,441,534 procedures performed, reflecting a 4% rise from 2022. Therefore, the rising demand for minimally invasive surgeries is fueling the growth of the medical device reimbursement market.
The increasing prevalence of chronic diseases is expected to drive the growth of the medical device reimbursement market. Chronic diseases are long-term conditions that can be managed but not cured. Reimbursement for medical devices plays a crucial role in managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes, while also reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity focused on heart and circulatory diseases, reported that about 7.6 million people in the UK are living with such conditions. This number is projected to rise by 1 million by 2030 and by 2 million by 2040. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.
Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.
In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.
Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance
North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Devices Reimbursement Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medical devices reimbursement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical devices reimbursement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical devices reimbursement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.